Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
7.81
-0.17 (-2.13%)
Jul 9, 2026, 4:00 PM EDT - Market closed
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $425.02 million as of July 9, 2026. Its market cap has decreased by -30.63% in one year.
Market Cap
425.02M
Enterprise Value
122.85M
1-Year Change
-30.63%
Ranking
Category
Stock Price
$7.81
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $425.02M, an increase of 8.05%. That is a compound annual growth rate of 4.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 425.02M | -71.03% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 452.44M |
| Artiva Biotherapeutics | 452.36M |
| Eupraxia Pharmaceuticals | 451.39M |
| Verastem | 446.40M |
| Century Therapeutics | 438.26M |
| vTv Therapeutics | 429.74M |
| DiaMedica Therapeutics | 428.91M |
| Compass Therapeutics | 421.41M |